Ankur Drugs & Pharma Ltd
Fortune 500 2010
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Fortune 500 India
#483(2010)
#483(2010)
Financial Data 2012
Revenue
152
(INR Cr)
Net Operating Income
151
(INR Cr)
Assets
1,095
(INR Cr)
Profit
-307
(INR Cr)
Net Worth
238
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|
| Revenue (INR Cr) | 152 -80.7% | 786 -27.9% | 1090 7.4% | 1015 - |
| Net Operating Income (INR Cr) | 151 -81.63% | 825 -22.73% | 1067 10.58% | 965 43.33% |
| Profit (INR Cr) | -307 - | -69 - | 86 132.1% | 37 - |
| Assets (INR Cr) | 1095 -25.3% | 1465 12.0% | 1308 28.7% | 1016 - |
| Net Worth (INR Cr) | 238 -17.4% | 288 -19.3% | 357 31.5% | 272 23.8% |
| Employee Cost (INR Cr) | 19 -8.0% | 20 29.4% | 16 29.1% | 12 - |
| Interest Cost (INR Cr) | 58 | 121 | 81 | 54 |
| Cash & Bank Balance (INR Cr) | 2 | 3 | 9 | 16 |
| Total Debt (INR Cr) | 857 | 1157 | 950 | 745 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|
| Profit As % Of Revenues | - | - | 7.9% | 3.7% |
| Profit As % Of Assets | - | - | 6.6% | 3.7% |
| Profit As % Of Networth | - | - | 24.1% | 13.7% |
| Interest Cost to EBITDA % | - | 90.2% | 38.7% | 41.4% |
| Debt to Equity Ratio | 3.59 | 4.01 | 2.66 | 2.74 |
| RONW | - | - | 27.4% | 15.1% |
| ROCE | 0.0% | 5.4% | 17.6% | 12.2% |